Atopic Dermatitis and Alopecia Areata Treatment: Beyond the Basics

Following the 2022 presentation, “JAK Inhibitors and the Changing Landscape of Atopic Dermatitis and Alopecia Areata Management,” this ASHP webinar will delve further into the specific nuances of treating the disease states of atopic dermatitis (AD) and alopecia areata (AA). Specifically, treatment of AD and AA in special patient populations, such as pediatrics and pregnancy, will be addressed. In addition, faculty will provide recommendations that learners can apply to challenging management scenarios of patients with AD and AA.


Wednesday, Mar. 22
12 - 1 p.m. ET

Speakers

Jamie McConaha

Jamie L. McConaha, PharmD, NCTTP, BCACP, CDCES, Activity Chair
Associate Professor of Pharmacy Practice
Duquesne University School of Pharmacy
Pittsburgh, Pennsylvania

Monica DoughertyMonica Dougherty PharmD, BCACP
Clinical Pharmacy Specialist
University of Rochester Medical Center
Rochester, New York



Target Audience

This activity was planned to meet the educational needs of pharmacists involved in the care of patients with atopic dermatitis and alopecia areata.

Learning Objectives

  • Summarize evidence-based therapies for the treatment of atopic dermatitis and alopecia areata in pediatric patients, including newer therapies with novel mechanisms of action.
  • Apply counseling pearls when interacting with patients treated with biologic therapies and JAK inhibitors.
  • Design a treatment plan for challenging cases of patients with atopic dermatitis and alopecia areata, including patients with serious adverse effects or financial limitations.

Agenda

  • 12:00 p.m. - Introductions
    Jamie L. McConaha, PharmD, NCTTP, BCACP, CDCES
  • 12:05 p.m. - Summary of Treatment of Atopic Dermatitis (AD) and Alopecia Areata (AA)
    Jamie L. McConaha, PharmD, NCTTP, BCACP, CDCES
  • 12:15 p.m. - Pharmacist Counseling Pearls
    Monica Dougherty, PharmD, BCACP
  • 12:25 p.m. - Managing AD and AA in Pediatric Patients
    Jamie L. McConaha, PharmD, NCTTP, BCACP, CDCES
  • 12:35 p.m. - Addressing Challenging Patient Cases
    Monica Dougherty, PharmD, BCACP
  • 12:50 p.m. - Faculty Discussion and Questions & Answers
    All Faculty

Accredited for CPE

ACPE #: 0204-0000-23-420-L01-P
CE Credit: 1.0 contact hours (0.10 CEUs)
Activity Type: Application-based
Activity Fee: No Charge

To Claim CE for the webinar, enter the CE code announced during the activity and complete the evaluation.

 

 

ACPE logo The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
ASHP Advantage logo Provided by ASHP. Supported by an educational grant from Pfizer Inc. For questions and assistance to participate, contact us.